Avadel Pharmaceuticals PLC
(STU:AWK)
€
9.85
0.4 (4.23%)
Market Cap: 949.15 Mil
Enterprise Value: 888.38 Mil
PE Ratio: 0
PB Ratio: 13.32
GF Score: 40/100 Avadel Pharmaceuticals PLC at H C Wainwright BioConnect Conference (Virtual) Transcript
Jan 11, 2021 / NTS GMT
Release Date Price:
€5.5
(+0.92%)
Oren Gabriel Livnat
H.C. Wainwright & Co, LLC, Research Division - MD & Senior Healthcare Analyst
Welcome to the H.C. Wainwright 2021 BioConnect Conference. My name is Oren Livnat, the spec pharma analyst here at H.C. Wainwright. It's my pleasure to welcome our presenter, Avadel. And with us today is CEO, Greg Divis. Welcome, Greg.
Gregory J. Divis
Avadel Pharmaceuticals plc - CEO & Director
Thank you, Oren, a pleasure to be here, appreciate the opportunity.
Oren Gabriel Livnat
H.C. Wainwright & Co, LLC, Research Division - MD & Senior Healthcare Analyst
No problem.
Questions & Answers
Oren Gabriel Livnat
H.C. Wainwright & Co, LLC, Research Division - MD & Senior Healthcare Analyst
So we spoke a few months ago, and did one of these fireside chats. And since then, you guys have come through and filed the on-time the NDA for FT218, your once-nightly sodium oxybate for narcolepsy, which for those who don't know, is essentially a new and
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot